Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial investigating the effect of nutritional management on patients with nasopharyngeal carcinoma undergoing concurrent ch…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity [Phase 3]
A phase 3 clinical trial update describing a protocol to shrink the anterior border of the CTV2 target volume in nasopharyngeal carcinoma to…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy [Phase 2]
A Phase 2 trial investigating the combination of tislelizumab and capecitabine for nasopharyngeal carcinoma with residual EBV DNA after radi…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with radiotherapy for oligometastatic nasopharyngeal carcinoma, currently recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Adjuvant vs Surgery Only in Early-stage Recurrent NPC [Phase 3]
A Phase 3 clinical trial comparing adjuvant therapy versus surgery alone for early-stage recurrent nasopharyngeal carcinoma is currently rec…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC [Phase 2]
Phase 2 clinical trial evaluating two-cycle and three-cycle induction therapy with a modified TPF chemotherapy regimen plus Camrelizumab for…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy [Phase 2]
A Phase 2 clinical trial evaluating the combination of SBRT with Nimotuzumab and Tislelizumab for oligoprogressive recurrent/metastatic naso…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) [Phase 1, Phase 2]
A phase 1/2 randomized trial evaluating spermidine to prevent radiation-induced xerostomia in patients with head and neck cancers, including…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Screening for Early Diagnosis of Nose Cancer [NA]
A clinical trial sponsored by National University Hospital, Singapore is recruiting to study screening for early diagnosis of nasopharyngeal…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.
A clinical trial update evaluating brain changes detected by multiplex MRI in nasopharyngeal carcinoma patients after treatment and how thes…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma [Phase 3]
Phase III non-inferiority trial comparing proton therapy versus photon therapy for nasopharyngeal carcinoma is currently recruiting. The stu…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC [Phase 3]
Phase 3 clinical trial comparing neoadjuvant versus adjuvant treatment for locally advanced recurrent nasopharyngeal carcinoma; currently re…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating KL-A167 plus cisplatin and gemcitabine versus placebo with cisplatin and gemcitabine for recurrent or metastatic na…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial [Phase 2]
A Phase 2, single-arm clinical trial assessing the TC regimen as adjuvant therapy after surgery for locally recurrent resectable nasopharyng…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. [Phase 3]
This clinical-trial update announces a Phase 3 study evaluating QL1706, a PD-1/CTLA-4 bispecific antibody, in combination with chemoradiothe…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating TN induction and adjuvant therapy for resectable local recurrent nasopharyngeal carcinoma is currently r…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating an EGFR-targeting antibody in combination with a PD-1 inhibitor and chemotherapy for recurren…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating radiotherapy with nimotuzumab or cisplatin in nasopharyngeal carcinoma; the study is currently active but …
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Application of 18F-FDG PET/MRI for Initial Staging in Locally Advanced Nasopharyngeal Carcinoma
This clinical trial entry describes evaluating the use of 18F-FDG PET/MRI for initial staging in locally advanced nasopharyngeal carcinoma, …
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating reduced-dose radiotherapy versus standard-dose radiotherapy for early-stage nasopharyngeal carcinoma; curr…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma [NA]
UCSF-sponsored study on induction chemotherapy response-guided radiation for EBV-associated nasopharyngeal carcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC [Phase 3]
A Phase 3 clinical trial evaluating optimized prophylactic radiotherapy to preserve thyroid function in nasopharyngeal carcinoma is currentl…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
This Clinical Trial Update describes a Phase II randomized, double-blind, placebo-controlled multicenter study evaluating Nituzumab (Taixins…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating chemotherapy with or without toripalimab for primary metastatic nasopharyngeal carcinoma; the study is active but n…